Intravenous Semelil (ANGIPARSTM) as a novel therapy for pressure ulcers: A randomized clinical trial

Shamimi Nouri, K., R. Heshmat, R. Karimian, E. Nasli, B. Larijani, Y.A. Novitsky, M. Farhadi and F. Gharibdoust (2008) Intravenous Semelil (ANGIPARSTM) as a novel therapy for pressure ulcers: A randomized clinical trial. [Publication]

Full text not available from this repository.
Item Type: Publication
Author(s): Shamimi Nouri, K., R. Heshmat, R. Karimian, E. Nasli, B. Larijani, Y.A. Novitsky, M. Farhadi and F. Gharibdoust
Author(s) order (without accents): Shamimi Nouri K R Heshmat, R Karimian E Nasli B Larijani YA Novitsky M Farhadi and F Gharibdoust
Title order (without accents): Intravenous Semelil (ANGIPARSTM) as a novel therapy for pressure ulcers: A randomized clinical trial
Type of publication: Article / Letter to editor
Language: English
Published in: DARU 16, Suppl. 1, 49--53
Location: internet
Additional info: Semelil contains Melilotus officinalis Willd.
Checked: yes
ReferenceID: 98s
Date Deposited: 07 Jul 2017 12:32
Last Modified: 07 Jul 2017 12:32
URI: http://indianmedicine.eldoc.ub.rug.nl/id/eprint/49370

Actions (login required)

View Item View Item